Hi All, A concept floated around to consolidate the merits of the stocks being discussed on biotech startups to arrive at investment sentiments which might provide guidelines, but not recommendations on investments. Gummies are responsible to take their individual decisions and benefit out of the effort put forth by KSS and team in identifying promising […]
Microblogs
December 11, 2014
On delta-9 Cannabalis Technologies Inc (CTI)
Hi Doc, There is a teaser which talks about 3 hot companies working on pain relieving which can provide huge gains apparently. It mentions about an Arizona and Vancouver-based companies .. http://www.angelnexus.com/o/web/68345/ Google search for delta-9 gave the following companies which are doing phase3 clinical trials .. InMed Pharmaceuticals http://investorshub.advfn.com/InMed-Pharmaceuticals-Inc-IMLFF-28415/ http://www.marketwatch.com/story/inmed-pharma-proprietary-platform-growing-pipeline-low-valuation-2014-10-29 GW Pharma and Insys […]
Recent Author Comments
Posted on January 28, 2017
Posted on January 28, 2017
Thanks[...]
Posted on January 27, 2017
Hi Trevis,Could you please take a look at this article and give your opinion ? Things might change.https://globenewswire.com/news-release/2016/08/01/860508/10164353/en/STMicroelectronics-Earns-MEMS-Manufacturer-of-the-Year-Award.htmlSHANGHAI, China[...]
Posted on May 10, 2016
Will the commercialization of the product have to wait for the patents to be approved ? If it takes more time for the patents to be approved, can they go to the market with patent pending status ? Probably they are timing the filing of patents to coincid[...]
Posted on May 10, 2016
Another reference to the sales vs production cost, but not quantified though. All that google could provide during the search, if it helps ... http://archtherapeutics.blogspot.in/5) Potentially extraordinary gross profit margins—At scale $ 400-[...]
Posted on May 10, 2016
They have a pdf download as well http://www.redchip.com/assets/reports/ARTH_FactSheet_20150518.pdf[...]
Posted on May 10, 2016
Cost of AC5 solutions Perhaps it came from RedChip interview. Norchi also mentions in the interview that one of the value propositions of AC5 is "High Margins and Low Cost to Market" http://www.redchip.com/company/home/ARTH/257/healthcareInvestment[...]
Posted on April 29, 2016
This agency says 9-week period CE mark approval for a medical device with its FastTrack programmes:http://www.bsigroup.com/en-GB/medical-devices/our-services/ce-marking-speed-to-market/More info on CE approval for medical devices http://www.emergo[...]
Posted on April 29, 2016
Excellent ! So technically we are close to end of phase I http://www.stockgumshoe.com/2015/03/microblog-primer-on-drug-development/ As was reiterated this being a medical device should complete the process faster I hope.[...]
Posted on April 29, 2016
I know. I have been following these articles. But we are dealing with human minds and emotions. It needs confirmation from different sources no matter how solid the foundation was laid here. Quoting from different reliable sources leading to the same con[...]
Posted on April 28, 2016
Not sure how to read the assets and liabilities table. But if there cash assets are $ 1.6 m, with CURAM doubly matching Arch's spending and their judicious spending, they may well be able to get past the financial hurdle ($ 3m) for human trials to get C[...]
Posted on April 28, 2016
Might be worth reading this article on seekingalpha - positive on Arch with good pros and cons analysis http://seekingalpha.com/article/3964460-tiny-arch-therapeutics-just-doubled-time-dump[...]
Posted on February 18, 2015
Thanks Curt. Further clarification is much appreciated. Is the success of ARTH still to be viewed as a binary event ? I suppose the grant of medical device designation reduces the risk factor. Does the grant entitle ARTH to proceed further with commerci[...]
Posted on February 18, 2015
Hi Doc,I had to move to a new place for a project. Yet to catch up with the developments happening around here. I received the following notification from Arch therapeutics. Sounds positive to me. How far off is in the evaluation process without hu[...]
Posted on January 21, 2015
Can anyone explain why the biotech stocks are going down today ?[...]
Posted on January 21, 2015
TRIL @ 13.75, kpti @ 26.24[...]
Posted on January 21, 2015
Good review on bloomberg .. http://www.bloomberg.com/news/2015-01-20/shake-shack-seeks-up-to-80-million-ipo-of-meyer-s-burger-chain.html[...]
Posted on January 21, 2015
thanks doc[...]
Posted on January 20, 2015
Hi Doc,Zosano is offering IPO shares on Jan 26th. It struck a deal with NVO on type 2 diabetes in Feb '14http://www.bizjournals.com/sanfrancisco/blog/biotech/2014/02/zosano-novo-nordisk-diabetes-patch.html?page=alland in november it signed a p[...]
Posted on January 19, 2015
Thanks a lot Ben .. I just registered myself to this newsletter .. I am happy I could be of some helpRegards, s_t[...]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info Please note that this is your publicly visible biography - we recommend not including any personal information (phone, email, address, etc.) and ONLY linking to any other pages or profiles you're comfortable sharing with everyone.
Tab memory usage is a good one. Perhaps this add-on can be tried too.https://addons.mozilla.org/en-US/firefox/addon/apptelemetry/This app gives a comprehensive time taken for different activities in loading the page.Perhaps this information [...]